Hemochromatosis Gene Mutation in Persons Developing Erythrocytosis on Combined Testosterone and SGLT-2 Inhibitor Therapy

In clinical trials, sodium-glucose cotransporter-2 inhibitors (SGLT-2i) use alone in persons with type 2 diabetes (T2D) or testosterone replacement therapy (TRT) prescription alone in men with hypogonadism was shown to lead to a modest but significant increase in red blood cell mass. Recent evidence...

Descripción completa

Detalles Bibliográficos
Autores principales: Schumacher, Kamilya A., Gosmanov, Aidar R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290160/
https://www.ncbi.nlm.nih.gov/pubmed/35848311
http://dx.doi.org/10.1177/23247096221111774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290160/
https://www.ncbi.nlm.nih.gov/pubmed/35848311
http://dx.doi.org/10.1177/23247096221111774

Ejemplares similares